Replies to post #233305 on Amarin Corp Plc (AMRN)

[marjac]

Not the whole link, but TerraPharma on Twitter had the key excerpt, which is awesome for longs, and devastating for shorts.

BROAD label coming...”FDA found that the results of the primary endpoint were consistent across multiple subgroups...baseline characteristics...biomarkers (such as TG and hsCRP levels)...and the two CV risk categories.” pic.twitter.com/PNnHu5UBPK

— Steve Toneatti (@stoneatti) December 13, 2019

This should also serve as notice to all those Nervous Nellies who are irrationally speculating that the length of the halt somehow means that the news is negative for our majestic Amarin.